| Clinicopathologic and genomic landscape of non-small cell lung cancer brain metastases RSP Huang, L Harries, B Decker, MC Hiemenz, K Murugesan, J Creeden, ... The Oncologist 27 (10), 839-848, 2022 | 22 | 2022 |
| Clinicopathologic and genomic characterization of PD‐L1 positive urothelial carcinomas RSP Huang, J Haberberger, L Harries, E Severson, DL Duncan, ... The Oncologist 26 (5), 375-382, 2021 | 9 | 2021 |
| POU2AF3‐rearranged sarcomas: A novel tumor defined by fusions of EWSR1 or FUS to a gene formerly designated COLCA2 MC Hiemenz, J Kaur, Z Kuang, RSP Huang, L Harries, D Metzger, ... Genes, Chromosomes and Cancer 62 (8), 460-470, 2023 | 6 | 2023 |
| Method of tissue acquisition affects success of comprehensive genomic profiling in lung cancer DA Mata, L Harries, EA Williams, MC Hiemenz, B Decker, JY Tse, ... Archives of Pathology & Laboratory Medicine 147 (3), 338-347, 2023 | 5 | 2023 |
| Real-world comprehensive genomic profiling success rates in tissue and liquid prostate carcinoma specimens MC Hiemenz, RP Graf, K Schiavone, L Harries, GR Oxnard, JS Ross, ... The Oncologist 27 (12), e970-e972, 2022 | 5 | 2022 |
| Variable Genomic Landscapes of Advanced Melanomas with Heavy Pigmentation RSP Huang, JY Tse, L Harries, RP Graf, DI Lin, K Murugesan, ... The Oncologist 27 (8), 655-662, 2022 | 2 | 2022 |
| Phosphorylation Impact on the Behavior of Substrate‐Bound Tau L Harries, Z Donhauser The FASEB Journal 33 (S1), 779.16-779.16, 2019 | | 2019 |
